JPWO2020017620A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020017620A5
JPWO2020017620A5 JP2020531374A JP2020531374A JPWO2020017620A5 JP WO2020017620 A5 JPWO2020017620 A5 JP WO2020017620A5 JP 2020531374 A JP2020531374 A JP 2020531374A JP 2020531374 A JP2020531374 A JP 2020531374A JP WO2020017620 A5 JPWO2020017620 A5 JP WO2020017620A5
Authority
JP
Japan
Prior art keywords
salt
fatty acid
acid derivative
labeled fatty
heart disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020531374A
Other languages
English (en)
Japanese (ja)
Other versions
JP7375755B2 (ja
JPWO2020017620A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/028380 external-priority patent/WO2020017620A1/ja
Publication of JPWO2020017620A1 publication Critical patent/JPWO2020017620A1/ja
Publication of JPWO2020017620A5 publication Critical patent/JPWO2020017620A5/ja
Application granted granted Critical
Publication of JP7375755B2 publication Critical patent/JP7375755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020531374A 2018-07-20 2019-07-19 陽電子放出核種で標識された脂肪酸誘導体 Active JP7375755B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018136483 2018-07-20
JP2018136483 2018-07-20
PCT/JP2019/028380 WO2020017620A1 (ja) 2018-07-20 2019-07-19 陽電子放出核種で標識された脂肪酸誘導体

Publications (3)

Publication Number Publication Date
JPWO2020017620A1 JPWO2020017620A1 (ja) 2021-08-02
JPWO2020017620A5 true JPWO2020017620A5 (https=) 2022-06-20
JP7375755B2 JP7375755B2 (ja) 2023-11-08

Family

ID=69164918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020531374A Active JP7375755B2 (ja) 2018-07-20 2019-07-19 陽電子放出核種で標識された脂肪酸誘導体

Country Status (9)

Country Link
US (1) US12029797B2 (https=)
EP (1) EP3825302B1 (https=)
JP (1) JP7375755B2 (https=)
KR (1) KR102718221B1 (https=)
CN (1) CN112638868B (https=)
AU (1) AU2019304781B2 (https=)
CA (1) CA3106903A1 (https=)
ES (1) ES3009015T3 (https=)
WO (1) WO2020017620A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3009015T3 (en) 2018-07-20 2025-03-25 Astellas Pharma Inc Fatty acid derivative labeled with positron-emitting radionuclide
US20230065079A1 (en) * 2020-01-17 2023-03-02 Astellas Pharma Inc. Fatty acid derivative labeled with positron-emitting radionuclide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828623C2 (de) 1978-06-29 1983-11-17 Kernforschungsanlage Jülich GmbH, 5170 Jülich Mit radioaktivem Flour markierte C↓1↓↓6↓-bis C↓1↓↓8↓- Fettsäuren, ein Verfahren zu ihrer Herstellung sowie deren Verwendung
WO2000063216A1 (en) 1999-04-19 2000-10-26 Duke University F-18-labeled thia fatty acids and methods of making and using the same
CA2522737C (en) * 2003-04-17 2017-06-06 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
CN1217924C (zh) 2003-10-17 2005-09-07 江苏省原子医学研究所 一种氟标记脂肪酸心肌代谢显像剂14(r,s)-氟[18f]-6-硫十七烷酸的纯化方法
CA2760334A1 (en) 2009-05-04 2010-11-11 Washington University Pet radiotracers for imaging fatty acid metabolism and storage
WO2014179341A1 (en) 2013-04-29 2014-11-06 Matinas Biopharma, Inc. Treatment with omega-3 fatty acid compositions
WO2015023631A2 (en) 2013-08-12 2015-02-19 Carolyn Anderson Fatty acid analogs and their use
CN105523977B (zh) 2016-02-04 2017-05-24 河南中医学院 [11c]‑巯甲基脂肪酸的制备方法与应用
ES3009015T3 (en) 2018-07-20 2025-03-25 Astellas Pharma Inc Fatty acid derivative labeled with positron-emitting radionuclide
US20230065079A1 (en) 2020-01-17 2023-03-02 Astellas Pharma Inc. Fatty acid derivative labeled with positron-emitting radionuclide

Similar Documents

Publication Publication Date Title
JP2022043078A5 (https=)
JP2005526011A5 (https=)
JP2020169171A5 (https=)
JP2015508092A5 (https=)
JP2018529687A5 (https=)
JP2017537940A5 (https=)
JP2011504935A5 (https=)
JP2018518537A5 (https=)
JP2020507589A5 (https=)
JP2007520453A5 (https=)
JP2018538428A (ja) インドシアニングリーンの改善された製造方法
JP2010532340A5 (https=)
JP2020502047A5 (https=)
JP2015518821A5 (https=)
JPWO2020017620A5 (https=)
JP2007502295A5 (https=)
JP2020502268A5 (https=)
JP2015508068A5 (https=)
RU2012144438A (ru) Производные 1-(2-фторбифенил-4-ил)-алкилкарбоновой кислоты для лечения транстиретинового амилоидоза
JP2020073474A5 (https=)
JP2018518486A5 (https=)
JP2019529514A5 (https=)
JP2020505354A5 (https=)
JP2013523621A5 (https=)
JP2009040767A5 (https=)